Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Paula Riggs to Humans

This is a "connection" page, showing publications Paula Riggs has written about Humans.

 
Connection Strength
  
 
 
0.393
  
  1. Vidal C, Olsavsky AK, Riggs PD. Editorial: Adolescent Substance Use Prevention and Treatment Is Our Wheelhouse. J Am Acad Child Adolesc Psychiatry. 2025 Feb; 64(2):99-101.
    View in: PubMed
    Score: 0.022
  2. Riggs P. A Pragmatic Clinical Approach to Substance Abuse Prevention. Psychiatr Clin North Am. 2023 12; 46(4):741-748.
    View in: PubMed
    Score: 0.021
  3. Riggs P, Hinckley JD, Ross JM. Addressing Cannabis Use During Adolescence. Psychiatr Clin North Am. 2023 12; 46(4):xiii-xv.
    View in: PubMed
    Score: 0.021
  4. Riggs P, Hinckley JD, Ross JM. Addressing Cannabis Use During Adolescence. Child Adolesc Psychiatr Clin N Am. 2023 01; 32(1):xiii-xv.
    View in: PubMed
    Score: 0.020
  5. Riggs P. A Pragmatic Clinical Approach to Substance Abuse Prevention. Child Adolesc Psychiatr Clin N Am. 2023 01; 32(1):107-114.
    View in: PubMed
    Score: 0.020
  6. Riggs P. Editorial: Prescription for Addiction. J Am Acad Child Adolesc Psychiatry. 2019 07; 58(7):659-660.
    View in: PubMed
    Score: 0.016
  7. Hinckley JD, Riggs P. Integrated Treatment of Adolescents with Co-occurring Depression and Substance Use Disorder. Child Adolesc Psychiatr Clin N Am. 2019 07; 28(3):461-472.
    View in: PubMed
    Score: 0.016
  8. Hsiao RC, Riggs PD. The Changing Landscape of Adolescent Substance Treatment. Child Adolesc Psychiatr Clin N Am. 2016 Oct; 25(4):xv-xvi.
    View in: PubMed
    Score: 0.013
  9. Al-Tayyib AA, Koester S, Riggs P. Prescription opioids prior to injection drug use: Comparisons and public health implications. Addict Behav. 2017 02; 65:224-228.
    View in: PubMed
    Score: 0.013
  10. Robinson ZD, Riggs PD. Cooccurring Psychiatric and Substance Use Disorders. Child Adolesc Psychiatr Clin N Am. 2016 Oct; 25(4):713-22.
    View in: PubMed
    Score: 0.013
  11. LeNoue SR, Riggs PD. Substance Abuse Prevention. Child Adolesc Psychiatr Clin N Am. 2016 Apr; 25(2):297-305.
    View in: PubMed
    Score: 0.012
  12. Riggs P. Want change? Try honey instead of vinegar. J Am Acad Child Adolesc Psychiatry. 2015 Jun; 54(6):440-1.
    View in: PubMed
    Score: 0.012
  13. Martin A, Drell MJ, Brown LK, Axelson DA, Riggs PD. Hats off: Journal awards 2013. J Am Acad Child Adolesc Psychiatry. 2013 Dec; 52(12):1360-4.
    View in: PubMed
    Score: 0.011
  14. Riggs PD. Stimulant medication for ADHD not associated with subsequent substance use disorders. Evid Based Med. 2014 Apr; 19(2):78.
    View in: PubMed
    Score: 0.011
  15. Al-Tayyib AA, Rice E, Rhoades H, Riggs P. Association between prescription drug misuse and injection among runaway and homeless youth. Drug Alcohol Depend. 2014 Jan 01; 134:406-409.
    View in: PubMed
    Score: 0.011
  16. Tamm L, Adinoff B, Nakonezny PA, Winhusen T, Riggs P. Attention-deficit/hyperactivity disorder subtypes in adolescents with comorbid substance-use disorder. Am J Drug Alcohol Abuse. 2012 Jan; 38(1):93-100.
    View in: PubMed
    Score: 0.009
  17. Riggs PD, Winhusen T, Davies RD, Leimberger JD, Mikulich-Gilbertson S, Klein C, Macdonald M, Lohman M, Bailey GL, Haynes L, Jaffee WB, Haminton N, Hodgkins C, Whitmore E, Trello-Rishel K, Tamm L, Acosta MC, Royer-Malvestuto C, Subramaniam G, Fishman M, Holmes BW, Kaye ME, Vargo MA, Woody GE, Nunes EV, Liu D. Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. J Am Acad Child Adolesc Psychiatry. 2011 Sep; 50(9):903-14.
    View in: PubMed
    Score: 0.009
  18. Thurstone C, Salomensen-Sautel S, Riggs PD. How adolescents with substance use disorder spend research payments. Drug Alcohol Depend. 2010 Oct 01; 111(3):262-4.
    View in: PubMed
    Score: 0.008
  19. Riggs P. Non-medical use and abuse of commonly prescribed medications. Curr Med Res Opin. 2008 Mar; 24(3):869-77.
    View in: PubMed
    Score: 0.007
  20. Riggs P, Levin F, Green AI, Vocci F. Comorbid psychiatric and substance abuse disorders: recent treatment research. Subst Abus. 2008; 29(3):51-63.
    View in: PubMed
    Score: 0.007
  21. Riggs PD, Thompson LL, Tapert SF, Frascella J, Mikulich-Gilbertson S, Dalwani M, Laudenslager M, Lohman M. Advances in neurobiological research related to interventions in adolescents with substance use disorders: research to practice. Drug Alcohol Depend. 2007 Dec 01; 91(2-3):306-11.
    View in: PubMed
    Score: 0.007
  22. Riggs PD, Mikulich-Gilbertson SK, Davies RD, Lohman M, Klein C, Stover SK. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Arch Pediatr Adolesc Med. 2007 Nov; 161(11):1026-34.
    View in: PubMed
    Score: 0.007
  23. Libby AM, Riggs PD. Integrated substance use and mental health treatment for adolescents: aligning organizational and financial incentives. J Child Adolesc Psychopharmacol. 2005 Oct; 15(5):826-34.
    View in: PubMed
    Score: 0.006
  24. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-Concentration Delta-9-Tetrahydrocannabinol Cannabis Products and Mental Health Outcomes : A Systematic Review. Ann Intern Med. 2025 Oct; 178(10):1429-1440.
    View in: PubMed
    Score: 0.006
  25. Libby AM, Orton HD, Stover SK, Riggs PD. What came first, major depression or substance use disorder? Clinical characteristics and substance use comparing teens in a treatment cohort. Addict Behav. 2005 Oct; 30(9):1649-62.
    View in: PubMed
    Score: 0.006
  26. Riggs PD, Hall SK, Mikulich-Gilbertson SK, Lohman M, Kayser A. A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents. J Am Acad Child Adolesc Psychiatry. 2004 Apr; 43(4):420-9.
    View in: PubMed
    Score: 0.006
  27. Riggs PD. Treating adolescents for substance abuse and comorbid psychiatric disorders. Sci Pract Perspect. 2003 Aug; 2(1):18-29.
    View in: PubMed
    Score: 0.005
  28. Riggs PD, Davies RD. A clinical approach to integrating treatment for adolescent depression and substance abuse. J Am Acad Child Adolesc Psychiatry. 2002 Oct; 41(10):1253-5.
    View in: PubMed
    Score: 0.005
  29. Bonn-Miller MO, Sisley S, Riggs P, Yazar-Klosinski B, Wang JB, Loflin MJE, Shechet B, Hennigan C, Matthews R, Emerson A, Doblin R. The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial. PLoS One. 2021; 16(3):e0246990.
    View in: PubMed
    Score: 0.004
  30. Riggs PD, Mikulich SK, Whitmore EA, Crowley TJ. Relationship of ADHD, depression, and non-tobacco substance use disorders to nicotine dependence in substance-dependent delinquents. Drug Alcohol Depend. 1999 May 03; 54(3):195-205.
    View in: PubMed
    Score: 0.004
  31. Riggs PD, Leon SL, Mikulich SK, Pottle LC. An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry. 1998 Dec; 37(12):1271-8.
    View in: PubMed
    Score: 0.004
  32. Riggs PD. Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry. 1998 Mar; 37(3):331-2.
    View in: PubMed
    Score: 0.004
  33. Mikulich-Gilbertson SK, Wagner BD, Grunwald GK, Riggs PD, Zerbe GO. Using empirical Bayes predictors from generalized linear mixed models to test and visualize associations among longitudinal outcomes. Stat Methods Med Res. 2019 05; 28(5):1399-1411.
    View in: PubMed
    Score: 0.004
  34. Al-Tayyib A, Riggs P, Mikulich-Gilbertson S, Hopfer C. Prevalence of Nonmedical Use of Prescription Opioids and Association With Co-occurring Substance Use Disorders Among Adolescents in Substance Use Treatment. J Adolesc Health. 2018 02; 62(2):241-244.
    View in: PubMed
    Score: 0.004
  35. Riggs PD, Mikulich SK, Coffman LM, Crowley TJ. Fluoxetine in drug-dependent delinquents with major depression: an open trial. J Child Adolesc Psychopharmacol. 1997; 7(2):87-95.
    View in: PubMed
    Score: 0.003
  36. Harmon RJ, Riggs PD. Clonidine for posttraumatic stress disorder in preschool children. J Am Acad Child Adolesc Psychiatry. 1996 Sep; 35(9):1247-9.
    View in: PubMed
    Score: 0.003
  37. Riggs PD, Thompson LL, Mikulich SK, Whitmore EA, Crowley TJ. An open trial of pemoline in drug-dependent delinquents with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1996 Aug; 35(8):1018-24.
    View in: PubMed
    Score: 0.003
  38. Wagner B, Riggs P, Mikulich-Gilbertson S. The importance of distribution-choice in modeling substance use data: a comparison of negative binomial, beta binomial, and zero-inflated distributions. Am J Drug Alcohol Abuse. 2015; 41(6):489-97.
    View in: PubMed
    Score: 0.003
  39. Riggs PD, Baker S, Mikulich SK, Young SE, Crowley TJ. Depression in substance-dependent delinquents. J Am Acad Child Adolesc Psychiatry. 1995 Jun; 34(6):764-71.
    View in: PubMed
    Score: 0.003
  40. Benningfield MM, Riggs P, Stephan SH. The role of schools in substance use prevention and intervention. Child Adolesc Psychiatr Clin N Am. 2015 Apr; 24(2):291-303.
    View in: PubMed
    Score: 0.003
  41. Mikulich-Gilbertson SK, Wagner BD, Riggs PD, Zerbe GO. On estimating and testing associations between random coefficients from multivariate generalized linear mixed models of longitudinal outcomes. Stat Methods Med Res. 2017 Jun; 26(3):1130-1145.
    View in: PubMed
    Score: 0.003
  42. Crowley TJ, Riggs PD. Adolescent substance use disorder with conduct disorder and comorbid conditions. NIDA Res Monogr. 1995; 156:49-111.
    View in: PubMed
    Score: 0.003
  43. Tamm L, Trello-Rishel K, Riggs P, Nakonezny PA, Acosta M, Bailey G, Winhusen T. Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder. J Subst Abuse Treat. 2013 Feb; 44(2):224-30.
    View in: PubMed
    Score: 0.002
  44. Winhusen TM, Lewis DF, Riggs PD, Davies RD, Adler LA, Sonne S, Somoza EC. Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011 Oct; 21(5):455-63.
    View in: PubMed
    Score: 0.002
  45. Warden D, Riggs PD, Min SJ, Mikulich-Gilbertson SK, Tamm L, Trello-Rishel K, Winhusen T. Major depression and treatment response in adolescents with ADHD and substance use disorder. Drug Alcohol Depend. 2012 Jan 01; 120(1-3):214-9.
    View in: PubMed
    Score: 0.002
  46. Gray KM, Riggs PD, Min SJ, Mikulich-Gilbertson SK, Bandyopadhyay D, Winhusen T. Cigarette and cannabis use trajectories among adolescents in treatment for attention-deficit/hyperactivity disorder and substance use disorders. Drug Alcohol Depend. 2011 Sep 01; 117(2-3):242-7.
    View in: PubMed
    Score: 0.002
  47. Thurstone C, Riggs PD, Salomonsen-Sautel S, Mikulich-Gilbertson SK. Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder. J Am Acad Child Adolesc Psychiatry. 2010 Jun; 49(6):573-82.
    View in: PubMed
    Score: 0.002
  48. Jaffee WB, Bailey GL, Lohman M, Riggs P, McDonald L, Weiss RD. Methods of recruiting adolescents with psychiatric and substance use disorders for a clinical trial. Am J Drug Alcohol Abuse. 2009; 35(5):381-4.
    View in: PubMed
    Score: 0.002
  49. Thurstone C, Riggs PD, Klein C, Mikulich-Gilbertson SK. A one-session human immunodeficiency virus risk-reduction intervention in adolescents with psychiatric and substance use disorders. J Am Acad Child Adolesc Psychiatry. 2007 Sep; 46(9):1179-1186.
    View in: PubMed
    Score: 0.002
  50. Drell MJ, Josephson A, Pleak R, Riggs P, Rosenfeld A. Clinical problem solving: the case of John, Part III. J Am Acad Child Adolesc Psychiatry. 2006 Nov; 45(11):1370-80.
    View in: PubMed
    Score: 0.002
  51. Drell MJ, Josephson A, Pleak R, Riggs P, Rosenfeld A. Clinical problem solving: the case of John, Part II: excerpts from Sessions 2-7. J Am Acad Child Adolesc Psychiatry. 2006 Oct; 45(10):1243-51.
    View in: PubMed
    Score: 0.002
  52. Drell MJ, Josephson A, Pleak R, Riggs P, Rosenfeld A. Clinical problem solving: the case of John, part I. J Am Acad Child Adolesc Psychiatry. 2006 Sep; 45(9):1124-31.
    View in: PubMed
    Score: 0.002
  53. Helstrom A, Bryan A, Hutchison KE, Riggs PD, Blechman EA. Tobacco and alcohol use as an explanation for the association between externalizing behavior and illicit drug use among delinquent adolescents. Prev Sci. 2004 Dec; 5(4):267-77.
    View in: PubMed
    Score: 0.001
  54. Deas D, Riggs P, Langenbucher J, Goldman M, Brown S. Adolescents are not adults: developmental considerations in alcohol users. Alcohol Clin Exp Res. 2000 Feb; 24(2):232-7.
    View in: PubMed
    Score: 0.001
  55. Whitmore EA, Mikulich SK, Thompson LL, Riggs PD, Aarons GA, Crowley TJ. Influences on adolescent substance dependence: conduct disorder, depression, attention deficit hyperactivity disorder, and gender. Drug Alcohol Depend. 1997 Aug 25; 47(2):87-97.
    View in: PubMed
    Score: 0.001
  56. Thompson LL, Riggs PD, Mikulich SK, Crowley TJ. Contribution of ADHD symptoms to substance problems and delinquency in conduct-disordered adolescents. J Abnorm Child Psychol. 1996 Jun; 24(3):325-47.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)